{"id":"https://openalex.org/W2111243367","doi":"https://doi.org/10.1002/hup.470010206","title":"L\u2010Tryptophan and prolactin release: Evidence for interaction between 5\u2010HT1 and 5\u2010HT2 receptors","display_name":"L\u2010Tryptophan and prolactin release: Evidence for interaction between 5\u2010HT1 and 5\u2010HT2 receptors","alternate_titles":[],"publication_year":1986,"publication_date":"1986-12-01","ids":{"openalex":"https://openalex.org/W2111243367","doi":"https://doi.org/10.1002/hup.470010206","mag":"2111243367"},"language":"en","primary_location":{"id":"doi:10.1002/hup.470010206","doi":"https://doi.org/10.1002/hup.470010206","is_oa":false,"landing_page_url":"https://doi.org/10.1002/hup.470010206","pdf_url":null,"source":{"id":"https://openalex.org/S154207414","display_name":"Human Psychopharmacology Clinical and Experimental","issn_l":"0885-6222","issn":["0885-6222","1099-1077"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Human Psychopharmacology: Clinical and Experimental","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2111243367"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5050538701","display_name":"E. M. Charig","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]},{"id":"https://openalex.org/I4210157844","display_name":"Littlemore Hospital","ror":"https://ror.org/03exj3651","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210157844"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"E. M. Charig","raw_affiliation_strings":["Oxford University Department of Psychiatry and MRC Clinical Pharmacology Unit, Research Unit, Littlemore Hospital, Oxford OX4 4XN, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oxford University Department of Psychiatry and MRC Clinical Pharmacology Unit, Research Unit, Littlemore Hospital, Oxford OX4 4XN, UK","institution_ids":["https://openalex.org/I40120149","https://openalex.org/I4210157844"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067962994","display_name":"Ian Muir Anderson","orcid":"https://orcid.org/0000-0003-2205-9209","observed_orcids":["https://orcid.org/0000-0003-2205-9209"]},"institutions":[{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]},{"id":"https://openalex.org/I4210157844","display_name":"Littlemore Hospital","ror":"https://ror.org/03exj3651","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210157844"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"I. M. Anderson","raw_affiliation_strings":["Oxford University Department of Psychiatry and MRC Clinical Pharmacology Unit, Research Unit, Littlemore Hospital, Oxford OX4 4XN, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oxford University Department of Psychiatry and MRC Clinical Pharmacology Unit, Research Unit, Littlemore Hospital, Oxford OX4 4XN, UK","institution_ids":["https://openalex.org/I40120149","https://openalex.org/I4210157844"]}]},{"author_position":"middle","author":{"id":null,"display_name":"J. M. Robinson Sen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]},{"id":"https://openalex.org/I4210157844","display_name":"Littlemore Hospital","ror":"https://ror.org/03exj3651","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210157844"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"J. M. Robinson Sen","raw_affiliation_strings":["Oxford University Department of Psychiatry and MRC Clinical Pharmacology Unit, Research Unit, Littlemore Hospital, Oxford OX4 4XN, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oxford University Department of Psychiatry and MRC Clinical Pharmacology Unit, Research Unit, Littlemore Hospital, Oxford OX4 4XN, UK","institution_ids":["https://openalex.org/I40120149","https://openalex.org/I4210157844"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016082897","display_name":"David John Nutt","orcid":"https://orcid.org/0000-0002-1286-1401","observed_orcids":["https://orcid.org/0000-0002-1286-1401","https://orcid.org/0000-0002-6423-9411"]},"institutions":[{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]},{"id":"https://openalex.org/I4210157844","display_name":"Littlemore Hospital","ror":"https://ror.org/03exj3651","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210157844"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"D. J. Nutt","raw_affiliation_strings":["Oxford University Department of Psychiatry and MRC Clinical Pharmacology Unit, Research Unit, Littlemore Hospital, Oxford OX4 4XN, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oxford University Department of Psychiatry and MRC Clinical Pharmacology Unit, Research Unit, Littlemore Hospital, Oxford OX4 4XN, UK","institution_ids":["https://openalex.org/I40120149","https://openalex.org/I4210157844"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5023209431","display_name":"Philip J. Cowen","orcid":"https://orcid.org/0000-0001-5518-6138","observed_orcids":["https://orcid.org/0000-0001-5518-6138"]},"institutions":[{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]},{"id":"https://openalex.org/I4210157844","display_name":"Littlemore Hospital","ror":"https://ror.org/03exj3651","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210157844"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"P. J. Cowen","raw_affiliation_strings":["Oxford University Department of Psychiatry and MRC Clinical Pharmacology Unit, Research Unit, Littlemore Hospital, Oxford OX4 4XN, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oxford University Department of Psychiatry and MRC Clinical Pharmacology Unit, Research Unit, Littlemore Hospital, Oxford OX4 4XN, UK","institution_ids":["https://openalex.org/I40120149","https://openalex.org/I4210157844"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5023209431"],"corresponding_institution_ids":["https://openalex.org/I40120149","https://openalex.org/I4210157844"],"apc_list":{"value":4030,"currency":"USD","value_usd":4030},"apc_paid":null,"fwci":2.2313,"has_fulltext":false,"cited_by_count":87,"citation_normalized_percentile":{"value":0.87655848,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":93},"biblio":{"volume":"1","issue":"2","first_page":"93","last_page":"97"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.4323999881744385,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.4323999881744385,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10748","display_name":"Growth Hormone and Insulin-like Growth Factors","score":0.350600004196167,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10489","display_name":"Regulation of Appetite and Obesity","score":0.08380000293254852,"subfield":{"id":"https://openalex.org/subfields/2807","display_name":"Endocrine and Autonomic Systems"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tryptophan","display_name":"tryptophan","score":0.996999979019165},{"id":"https://openalex.org/keywords/prolactin-secretion","display_name":"prolactin secretion","score":0.9639999866485596},{"id":"https://openalex.org/keywords/growth-hormone","display_name":"growth hormone","score":0.597000002861023},{"id":"https://openalex.org/keywords/5-ht1-receptors","display_name":"5-HT1 receptors","score":0.8100000023841858},{"id":"https://openalex.org/keywords/5-ht2-receptor","display_name":"5-HT2 receptor","score":1.0},{"id":"https://openalex.org/keywords/ritanserin","display_name":"ritanserin","score":0.8700000047683716},{"id":"https://openalex.org/keywords/receptor-interaction","display_name":"receptor interaction","score":0.6990000009536743},{"id":"https://openalex.org/keywords/serotonin","display_name":"serotonin","score":0.48100000619888306}],"concepts":[{"id":"https://openalex.org/C2777450907","wikidata":"https://www.wikidata.org/wiki/Q3937260","display_name":"Ritanserin","level":5,"score":0.9494820237159729},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.705834150314331},{"id":"https://openalex.org/C2779064019","wikidata":"https://www.wikidata.org/wiki/Q66590068","display_name":"Prolactin","level":3,"score":0.681247353553772},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6774141788482666},{"id":"https://openalex.org/C53910766","wikidata":"https://www.wikidata.org/wiki/Q238516","display_name":"5-HT receptor","level":4,"score":0.6463404893875122},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.6402087211608887},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.6029205918312073},{"id":"https://openalex.org/C25274449","wikidata":"https://www.wikidata.org/wiki/Q1805481","display_name":"Long-term potentiation","level":3,"score":0.5463226437568665},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.529226541519165},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5279768109321594},{"id":"https://openalex.org/C2776706248","wikidata":"https://www.wikidata.org/wiki/Q181003","display_name":"Tryptophan","level":3,"score":0.47792965173721313},{"id":"https://openalex.org/C2778122271","wikidata":"https://www.wikidata.org/wiki/Q410943","display_name":"Receptor antagonist","level":4,"score":0.4679742157459259},{"id":"https://openalex.org/C71315377","wikidata":"https://www.wikidata.org/wiki/Q11364","display_name":"Hormone","level":2,"score":0.31676048040390015},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2906455397605896},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2149440050125122},{"id":"https://openalex.org/C515207424","wikidata":"https://www.wikidata.org/wiki/Q8066","display_name":"Amino acid","level":2,"score":0.09323936700820923},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.07851892709732056}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1002/hup.470010206","doi":"https://doi.org/10.1002/hup.470010206","is_oa":false,"landing_page_url":"https://doi.org/10.1002/hup.470010206","pdf_url":null,"source":{"id":"https://openalex.org/S154207414","display_name":"Human Psychopharmacology Clinical and Experimental","issn_l":"0885-6222","issn":["0885-6222","1099-1077"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Human Psychopharmacology: Clinical and Experimental","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9074000120162964}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":25,"referenced_works":["https://openalex.org/W386149854","https://openalex.org/W1809659791","https://openalex.org/W1965260202","https://openalex.org/W1966801160","https://openalex.org/W1975054535","https://openalex.org/W1975078132","https://openalex.org/W1975614312","https://openalex.org/W1982507334","https://openalex.org/W1988733687","https://openalex.org/W1991077292","https://openalex.org/W2000270606","https://openalex.org/W2015797063","https://openalex.org/W2031757811","https://openalex.org/W2040890001","https://openalex.org/W2044452733","https://openalex.org/W2060172635","https://openalex.org/W2063523840","https://openalex.org/W2066094303","https://openalex.org/W2066663898","https://openalex.org/W2073924028","https://openalex.org/W2093640193","https://openalex.org/W2094526652","https://openalex.org/W2158294982","https://openalex.org/W2159116126","https://openalex.org/W2180031282"],"related_works":["https://openalex.org/W2066094303","https://openalex.org/W7220893594","https://openalex.org/W2063335539","https://openalex.org/W2319064429","https://openalex.org/W2088213941","https://openalex.org/W2106184593","https://openalex.org/W1980601164","https://openalex.org/W2013151465","https://openalex.org/W2087541403","https://openalex.org/W2068013902"],"abstract_inverted_index":{"The":[0,51],"effects":[1],"of":[2,29,37,49],"the":[3,10,43,59,86],"selective":[4],"5\u2010HT2":[5,70,76],"receptor":[6,77],"antagonist,":[7],"ritanserin,":[8],"on":[9],"growth":[11],"hormone":[12],"(GH)":[13],"and":[14,72],"prolactin":[15],"(PRL)":[16],"responses":[17,45,61,84],"to":[18,35,62],"intravenous":[19],"L\u2010tryptophan":[20],"(LTP)":[21],"were":[22],"assessed":[23],"in":[24,85],"8":[25],"normal":[26],"volunteers.":[27],"Administration":[28],"ritanserin":[30],"(40":[31],"mg":[32],"orally)":[33],"prior":[34],"infusion":[36],"LTP":[38,63],"(5":[39],"g)":[40],"significantly":[41],"enhanced":[42],"PRL":[44],"but":[46],"not":[47],"those":[48],"GH.":[50],"results":[52],"are":[53,64],"consistent":[54],"with":[55],"previous":[56],"proposals":[57],"that":[58,75],"endocrine":[60],"mediated":[65,83],"by":[66],"5\u2010HT1":[67,82],"rather":[68],"than":[69],"receptors":[71],"also":[73],"suggest":[74],"antagonists":[78],"may":[79],"increase":[80],"certain":[81],"human":[87],"brain.":[88]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2111243367","counts_by_year":[{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
